u 69593 has been researched along with quinpirole in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berzetei-Gurske, IP; Guerrieri, E; Schmidhammer, H; Spetea, M | 1 |
| Acri, JB; Izenwasser, S; Kunko, PM; Shippenberg, T | 1 |
| Acri, JB; Shippenberg, T; Thompson, AC | 1 |
| Butelman, ER; Kreek, MJ | 1 |
| Bisnaire, L; Graham, D; Hayton, S; Perreault, ML; Simms, J; Szechtman, H | 1 |
| Foster, JA; Graham, D; Perreault, ML; Scattolon, S; Szechtman, H; Wang, Y | 1 |
| Perreault, ML; Seeman, P; Szechtman, H | 1 |
| Fields, HL; Hjelmstad, GO; Ishikawa, J; Margolis, EB; Mitchell, JM | 1 |
| Beerepoot, P; Lam, V; Luu, A; Siebert, D; Szechtman, H; Tsoi, B | 1 |
| Andrés, ME; Escobar, AP; España, RA; Fuentealba, JA; González, MP; Gysling, K; Henny, P; Meza, RC; Noches, V | 1 |
10 other study(ies) available for u 69593 and quinpirole
| Article | Year |
|---|---|
Discovery and pharmacological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist.
Topics: Acetic Acid; Analgesics; Animals; Drug Discovery; Mice; Nociception; Pain; Phenethylamines; Receptors, Opioid, kappa | 2012 |
Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.
Topics: Animals; Benzazepines; Benzeneacetamides; Carrier Proteins; Caudate Nucleus; Dopamine Plasma Membrane Transport Proteins; Down-Regulation; Drug Administration Schedule; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Nucleus Accumbens; Putamen; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, kappa; Sulpiride; Synapses; Time Factors | 1998 |
Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
Topics: Animals; Autoreceptors; Benzeneacetamides; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Down-Regulation; Male; Microdialysis; Motor Activity; Neostriatum; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Synaptic Transmission | 2001 |
kappa-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D(2)-like receptor agonists.
Topics: Animals; Behavior, Animal; Benzazepines; Benzeneacetamides; Conscious Sedation; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Prolactin; Pyrrolidines; Quinpirole; Receptors, Dopamine D2; Receptors, Opioid, kappa; Tetrahydronaphthalenes | 2001 |
Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms.
Topics: Algorithms; Analgesics; Animals; Benzeneacetamides; Data Interpretation, Statistical; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Motor Activity; Pyrrolidines; Quinpirole; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, kappa; Receptors, Presynaptic; Synapses | 2006 |
Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.
Topics: Analgesics; Analysis of Variance; Animals; Autoradiography; Basal Ganglia; Benzeneacetamides; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Enkephalins; Gene Expression; In Situ Hybridization; Injections; Male; Motor Activity; Protein Precursors; Pyrrolidines; Quinpirole; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Opioid, kappa; RNA, Messenger; Sulfur Isotopes; Time Factors | 2007 |
Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
Topics: Algorithms; Animals; Benzazepines; Benzeneacetamides; Domperidone; Dopamine Agonists; Dopamine Antagonists; Hyperkinesis; Kinetics; Ligands; Male; Motor Activity; Obsessive-Compulsive Disorder; Pyrrolidines; Quinpirole; Raclopride; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, kappa; Stereotyped Behavior | 2007 |
Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition.
Topics: Action Potentials; Amygdala; Analgesics; Animals; Animals, Newborn; Benzeneacetamides; Dopamine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Lysine; Male; Neural Inhibition; Neural Pathways; Neurons; Patch-Clamp Techniques; Pyrrolidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2008 |
Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole.
Topics: Analgesics; Animals; Benzeneacetamides; Central Nervous System; Diterpenes, Clerodane; Dopamine; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Drug Synergism; Male; Motor Activity; Pyrrolidines; Quinpirole; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, kappa; Synaptic Transmission | 2008 |
Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
Topics: Analgesics, Opioid; Animals; Benzeneacetamides; Dopamine; Dopamine Agonists; Extracellular Space; Male; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Neurons; Nucleus Accumbens; Pyrrolidines; Quinpirole; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Opioid, kappa; Synapses; Synaptosomes; Tissue Culture Techniques | 2017 |